Biotech

All Articles

Aligos declares stage 2 MASH win, reducing liver excess fat as much as 46%

.Aligos Therapies is actually trumpeting a midstage gain in metabolic-dysfunction associated steatoh...

Basilea credit ratings $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's work building brand-new antifungals has actually received a substantial boo...

Capricor sells Europe rights to late-stage DMD therapy for $35M

.Possessing currently gathered up the USA liberties to Capricor Therapies' late-stage Duchenne muscl...

FDA junks adcomm for Applied's unusual illness drug

.After pushing the choice date for Applied Therapies' metabolic disorder drug govorestat, the FDA ha...

Novo inks $600M NanoVation offer to study genetic drugs ex-liver

.Novo Nordisk is actually proceeding its own push into genetic medications, agreeing to pay NanoVati...

Innovent links cytokine to intestines cancer cells reactions

.Innovent Biologics has actually produced the instance that its checkpoint inhibitor-cytokine fusion...

Merck, Daiichi ADC reaches objective in period 3 lung cancer cells research study

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina deepens AI focus with collab to pick cancer aim ats

.5 months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech has a...

Ascendis' dwarfism drug favorites in stage 3, threatens BioMarin

.Ascendis Pharma has actually become a prospective risk to BioMarin's Voxzogo, stating stage 3 devel...

Despite ph. 3 skip, Alkeus views path ahead for eye condition asset

.Though Alkeus Pharmaceuticals' oral eye ailment resource fell short to substantially decrease geogr...